Literature DB >> 32348606

Association between hyperglycemia and the malignant transformation of oral leukoplakia in China.

Jin Li1,2, Yang Liu1, Hua Zhang3, Hong Hua1.   

Abstract

OBJECTIVES: This study aimed to examine the association between hyperglycemia and the malignant transformation of oral leukoplakia (OLK). PATIENTS AND METHODS: This retrospective case-control study involved 133 patients with the malignant transformation of OLK into oral squamous cell carcinoma (case group) and 266 patients with untransformed OLK (control group). The clinical history and follow-up data included age, gender, lesion size and location, and fasting plasma glucose. Logistic regression analysis, Kaplan-Meier survival analysis, and univariate and multivariate Cox regression analyses were used to assess the effects of risk factors on the malignant transformation of OLK.
RESULTS: Hyperglycemia (adjusted hazard ratio [AHR] = 4.7, p = .001), non-homogenous OLK (AHR = 3.0, p < .001), location of the lesion on the ventral surface of the tongue or floor of the mouth (AHR = 3.6, p < .001), and epithelial dysplasia (AHR = 2.8, p = .005) had significant effects on the malignant transformation of OLK.
CONCLUSION: Hyperglycemia, non-homogenous OLK, location of the lesion on the ventral surface of the tongue or floor of the mouth, and epithelial dysplasia might be associated with malignant transformation of OLK.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  diabetes mellitus; head and neck cancer; hyperglycemia; oral cancer; oral leukoplakia; squamous cell carcinoma

Mesh:

Year:  2020        PMID: 32348606     DOI: 10.1111/odi.13372

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  4 in total

1.  Fatty acid synthase mediates high glucose-induced EGFR activation in oral dysplastic keratinocytes.

Authors:  David J Wisniewski; Tao Ma; Abraham Schneider
Journal:  J Oral Pathol Med       Date:  2021-08-23       Impact factor: 3.539

2.  Metformin Downregulates the Expression of Epidermal Growth Factor Receptor Independent of Lowering Blood Glucose in Oral Squamous Cell Carcinoma.

Authors:  Wei-Ming Wang; Si-Si Yang; Shu-Hui Shao; Huan-Quan Nie; Jing Zhang; Tong Su
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-09       Impact factor: 5.555

3.  Effect of clinical and histologic features on time to malignancy in 224 cases of oral leukoplakia treated by surgery.

Authors:  Jose Bagan; Miguel Martorell; Jose L Cebrián; Andrea Rubert; Leticia Bagán; Carlos Mezquida; David Hervás
Journal:  Clin Oral Investig       Date:  2022-04-26       Impact factor: 3.606

Review 4.  Malignant Transformation Rate of Non-reactive Oral Hyperkeratoses Suggests an Early Dysplastic Phenotype.

Authors:  Ivan J Stojanov; Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2021-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.